Market Alert: ASX200 at Critical Support – Reversal or Further Fall?
Source: TradingView, Analysis by Kapitales Research
The ASX200 index has taken a sharp hit recently, falling more than 16% from its all-time high price levels and now testing a critical support zone around 7,200. The index has taken support from a midterm ascending trendline and bounced back sharply. The RSI is dipping into oversold territory, which could suggest a short-term bounce is possible if sentiment stabilizes. If the ongoing tariff war between major global economies escalates further, it could deepen investor fears and push the index even lower, possibly toward 6,800 or even the 6,290 regions. On the other hand, if there's any easing in trade tensions or signs of policy support, it could see a technical rebound back toward 7,500–7,800 levels.
If the tariff war further escalates, especially between major trading partners like China and the U.S. or China and Australia, the S&P/ASX 200 will likely face increased downward pressure. Australia’s economy is deeply tied to exports, particularly commodities and resources, with China being a dominant trade partner. Escalation in tariffs could lead to reduced export volumes, strained corporate earnings in mining, agriculture, and manufacturing sectors, and inflation due to costlier imports. Additionally, a prolonged trade conflict may weigh on consumer confidence and business investment, increasing the chances of an economic slowdown or technical recession in Australia.
Conversely, market sentiment would recover sharply if tensions eased and a resolution or trade agreement was reached. This could trigger strong buying interest, especially in resource-heavy and export-oriented sectors.
⚠️ Impact of Tariff War Escalation (U.S. Point of View – Australia's Implication)
If the U.S. increases tariffs on Chinese goods or other global imports:
✅ Impact if Tensions Ease
If trade relations between the U.S. and China stabilize:
🌐 Tariff War: Key Market Driver Ahead
The ongoing tariff tensions have become a significant headwind for global equity markets and the ASX200. The next move in this trade conflict could heavily influence the index’s direction from the current critical levels.
🔺 If Tariff War Escalates
1. Market Sentiment May Worsen
Further escalation could spark panic selling across global markets, especially in trade-sensitive sectors like mining, energy, and manufacturing—key components of the ASX200.
2. Earnings Pressure on Exporters
Australian companies with significant exposure to China and other trade partners may see margins squeezed due to higher input costs and lower overseas demand.
🟢 If Tariff War Eases
1. Relief Rally Likely
A de-escalation or resolution could trigger a swift recovery in the ASX200, especially from oversold technical levels. The index could rebound toward 7,800–8,000.
2. Boost in Corporate Earnings Outlook
Reduced trade barriers would stabilize supply chains and improve export prospects for Australian firms, potentially lifting forward earnings estimates.
3. Foreign Inflows May Resume
Improved global sentiment may attract foreign investment into Australian equities, further strengthening the market.
📌 Conclusion:
Trade tensions from this point on could significantly impact the index's next movement. If tariff threats de-escalate, it may boost investor sentiment and support a potential rebound towards the 7,800 to 8,000 range. Conversely, if tensions escalate, it could dampen global risk appetite, pushing the index below the 7,100 marks, with potential downside targets around 6,800 or even 6,290.
This situation makes the current range a crucial inflection point where global macro events and technical positioning align. Traders and investors should remain vigilant, as the upcoming sessions could significantly influence the medium-term outlook for Australian equities.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
Mar 31, 2025
Mar 10, 2025
Mar 10, 2025
Mar 10, 2025
Mar 10, 2025
Mar 06, 2025
Apr 14, 2023
Apr 10, 2023
Apr 09, 2023
Mar 15, 2023
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.